Mouse myelomas and lymphomas in culture☆
References (48)
- et al.
Exptl cell res
(1964) - et al.
Immunochemistry
(1969) - et al.
Exptl cell res
(1962) - et al.
Biochem pharmacol
(1963) Biochim biophys acta
(1969)- et al.
Biochim biophys acta
(1963) Exptl cell res
(1962)- et al.
Exptl cell res
(1967) - et al.
J mol biol
(1965)
Exptl cell res
J mol biol
J mol biol
J mol biol
Int rev cytol
Biochim biophys acta
Can j genet cytol
Ann N Y acad sci
J natl cancer inst
Ann N Y acad sci
Cited by (375)
How antibodies fold
2010, Trends in Biochemical SciencesEts factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes
2008, Molecular ImmunologyThe Early History of Plasma Cell Tumors in Mice, 1954-1976<sup>†</sup>
2007, Advances in Cancer ResearchCitation Excerpt :They withdrew the paper from Science. Later Horibata and Harris (1970) repeated the work and published it. MC's laboratory established many lines in culture and became a source of tissue culture lines to the scientific community.
Thymidine secretion by hybridoma and myeloma cells
2006, Biochemical and Biophysical Research CommunicationsCitation Excerpt :107 macrophages in 1 ml for 24 h) [19,20], but the biological role or significance of this thymidine release remains unclear. It has been suggested that thymidine may be an effector molecule in macrophage-mediated regulation of cell growth, since some cells are particularly sensitive to thymidine and may be inhibited by micro-molar concentrations (4–10 μM) [19,21,22]. Moreover, in vivo secretion of thymidine by a cell may of course result in higher local in vivo concentrations than that obtained in cell culture supernatants.
17β-Hydroxysteroid dehydrogenase type 7 (Hsd17b7) reverts cholesterol auxotrophy in NS0 cells
2006, Journal of Biotechnology
- ☆
This investigation was supported by Public Health Service Research Grant, no. CA-10311-02 from the National Cancer Institute, and Damon Runyon Memorial Fund no. 942, 942A, 942B to Kengo Horibata; a Damon Runyon Memorial Fund Research Fellowship, no. DRF-400 to Alan W. Harris; and by Public Health Service Research Grant, no A105875 from the National Institute of Allergy and Infectious Diseases, and a Public Health Service Training Grant, no. CA0521301 from the National Cancer Institute, both to Dr Melvin Cohn.
- 1
Present address: The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital Post Office, Victoria 3050, Australia.